Luca Borgio

Luca Borgio serves as the Head of Operations at Resalis Therapeutics, overseeing drug development activities for ASO/RNA-based therapies targeting metabolic diseases and oncology. With extensive experience in project, program, and portfolio management, Borgio has successfully coordinated cross-functional teams, managed asset life-cycles, and collaborated with regulatory affairs to advance development pipelines. Prior roles include Global Development Programme Manager at Zambon, IT Director at seQure Life Sciences, and Project Manager at Aptuit, among others, demonstrating a robust background in drug discovery, clinical development, and operational leadership. Luca holds an MBA from IE Business School and multiple degrees in bioengineering and biological sciences.